W. Leroy Griffing

900 total citations
17 papers, 587 citations indexed

About

W. Leroy Griffing is a scholar working on Pathology and Forensic Medicine, Rheumatology and Surgery. According to data from OpenAlex, W. Leroy Griffing has authored 17 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in W. Leroy Griffing's work include Systemic Sclerosis and Related Diseases (9 papers), Eosinophilic Disorders and Syndromes (6 papers) and Eosinophilic Esophagitis (5 papers). W. Leroy Griffing is often cited by papers focused on Systemic Sclerosis and Related Diseases (9 papers), Eosinophilic Disorders and Syndromes (6 papers) and Eosinophilic Esophagitis (5 papers). W. Leroy Griffing collaborates with scholars based in United States and Canada. W. Leroy Griffing's co-authors include Gene G. Hunder, Brian R. Younge, Kenneth Calamia, Eric L. Matteson, Mehrdad Mazlumzadeh, Jörg J. Goronzy, Kirk A. Easley, Cornelia M. Weyand, Michael D. Crowell and Marcelo F. Vela and has published in prestigious journals such as The American Journal of Gastroenterology, Journal of the American Academy of Dermatology and Mayo Clinic Proceedings.

In The Last Decade

W. Leroy Griffing

15 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Leroy Griffing United States	11	239	233	178	158	92	17	587
Yehudit Monselise Israel	15	70 0.3×	140 0.6×	32 0.2×	148 0.9×	63 0.7×	23	589
Takeshi Tojo Japan	13	117 0.5×	285 1.2×	482 2.7×	93 0.6×	30 0.3×	21	839
G Pokorny Hungary	11	41 0.2×	375 1.6×	113 0.6×	113 0.7×	42 0.5×	18	623
G. Fraile Spain	11	79 0.3×	108 0.5×	109 0.6×	122 0.8×	16 0.2×	26	403
F. Frikha Tunisia	11	53 0.2×	208 0.9×	88 0.5×	156 1.0×	19 0.2×	107	450
Philipp Ströbel Germany	10	307 1.3×	236 1.0×	123 0.7×	201 1.3×	193 2.1×	15	782
Gemma Lepri Italy	15	227 0.9×	112 0.5×	585 3.3×	90 0.6×	12 0.1×	24	720
Jan Lenaerts Belgium	13	97 0.4×	354 1.5×	109 0.6×	41 0.3×	13 0.1×	36	622
M G Sabbadini Italy	10	250 1.0×	325 1.4×	60 0.3×	156 1.0×	7 0.1×	19	660
Andrea Hinojosa‐Azaola Mexico	15	195 0.8×	203 0.9×	78 0.4×	43 0.3×	5 0.1×	45	446

Countries citing papers authored by W. Leroy Griffing

Since Specialization

Citations

This map shows the geographic impact of W. Leroy Griffing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Leroy Griffing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Leroy Griffing more than expected).

Fields of papers citing papers by W. Leroy Griffing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Leroy Griffing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Leroy Griffing. The network helps show where W. Leroy Griffing may publish in the future.

Co-authorship network of co-authors of W. Leroy Griffing

This figure shows the co-authorship network connecting the top 25 collaborators of W. Leroy Griffing. A scholar is included among the top collaborators of W. Leroy Griffing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Leroy Griffing. W. Leroy Griffing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

DiCaudo, David J., et al.. (2025). Cutaneous Nodules and Inflammatory Arthritis: Two Illustrative Cases of Rare Mimics of Rheumatoid Arthritis. Journal of Clinical Medicine. 14(14). 4940–4940.

Griffing, W. Leroy, et al.. (2021). Progression of gastrointestinal symptoms over time in patients with systemic sclerosis. Rheumatology International. 41(7). 1281–1287. 6 indexed citations

Snyder, Diana L., Michael D. Crowell, Allon Kahn, et al.. (2021). Prevalence of Barrett's Esophagus in Female Patients With Scleroderma. The American Journal of Gastroenterology. 116(3). 517–521. 10 indexed citations

Horsley‐Silva, Jennifer L., Sarah B. Umar, Marcelo F. Vela, et al.. (2019). The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality. Diseases of the Esophagus. 32(5). 15 indexed citations

Nokes, Brandon, Rodrigo Cartin‐Ceba, Lois E. Krahn, et al.. (2019). Individuals With Scleroderma May Have Increased Risk of Sleep-Disordered Breathing. Journal of Clinical Sleep Medicine. 15(11). 1665–1669. 13 indexed citations

Mangold, Aaron R., et al.. (2018). Systemic scleroderma and lupus panniculitis with atypical clinical features: A case report and comprehensive review. JAAD Case Reports. 4(8). 789–793. 1 indexed citations

Carlson, Dustin A., Michael D. Crowell, Jessica Kimmel, et al.. (2016). Loss of Peristaltic Reserve, Determined by Multiple Rapid Swallows, Is the Most Frequent Esophageal Motility Abnormality in Patients With Systemic Sclerosis. Clinical Gastroenterology and Hepatology. 14(10). 1502–1506. 70 indexed citations

Crowell, Michael D., Sarah B. Umar, W. Leroy Griffing, et al.. (2016). Esophageal Motor Abnormalities in Patients With Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life. Clinical Gastroenterology and Hepatology. 15(2). 207–213.e1. 61 indexed citations

Winkelmann, Richard R., James A. Yiannias, David J. DiCaudo, et al.. (2014). Paclitaxel‐induced diffuse cutaneous sclerosis: a case with associated esophageal dysmotility, Raynaud's phenomenon, and myositis. International Journal of Dermatology. 55(1). 97–100. 12 indexed citations

10.

Dionisio, Paula, W. Leroy Griffing, John K. DiBaise, et al.. (2008). High Resolution Esophageal Manometry (HRM). The American Journal of Gastroenterology. 103. S18–S18.

11.

Mazlumzadeh, Mehrdad, Gene G. Hunder, Kirk A. Easley, et al.. (2006). Treatment of giant cell arteritis using induction therapy with high‐dose glucocorticoids: A double‐blind, placebo‐controlled, randomized prospective clinical trial. Arthritis & Rheumatism. 54(10). 3310–3318. 212 indexed citations

12.

O’Duffy, J. Desmond, W. Leroy Griffing, Chin-Yang Li, Manal F. Abdelmalek, & David H. Persing. (1999). Whipple's arthritis: Direct detection ofTropheryma whippelii in synovial fluid and tissue. Arthritis & Rheumatism. 42(4). 812–817. 62 indexed citations

13.

Winkelmann, R.K., et al.. (1991). Histopathologic Features of the l-Tryptophan-Related Eosinophilia-Myalgia (Fasciitis) Syndrome. Mayo Clinic Proceedings. 66(5). 457–463. 16 indexed citations

14.

Connolly, Suzanne M., et al.. (1990). Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome. Journal of the American Academy of Dermatology. 23(3). 451–457. 14 indexed citations

15.

Gertz, Morie A., Robert A. Kyle, W. Leroy Griffing, & Gene G. Hunder. (1986). Jaw Claudication in Primary Systemic Amyloidosis. Medicine. 65(3). 173–179. 54 indexed citations

16.

Griffing, W. Leroy, S. Breanndan Moore, Harvinder S. Luthra, Charles H. Mckenna, & C. Garrison Fathman. (1980). Associations of antibodies to native DNA with HLA-DRw3. A possible major histocompatibility complex-linked human immune response gene.. PubMed. 152(2 Pt 2). 319s–325s. 38 indexed citations

17.

Griffing, W. Leroy, et al.. (1974). A possible origin of intestinal gradients and their relation to motility. American Journal of Physiology-Legacy Content. 226(6). 1510–1515. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact